A call for pharmacogenovigilance and rapid falsification in the age of big data: Why not first road test your biomarker?

Document Type

Journal Article

Publisher

Mary Ann Liebert Inc.

Faculty

Faculty of Health, Engineering and Science

School

School of Medical Sciences

RAS ID

18167

Comments

Sardas S., Endrenyi L., Gursoy U.K., Hutz M., Lin B., Patrinos G.P., Steuten L.M.G., Wang W., Warnich L., & Ozdemir V. (2014). A call for pharmacogenovigilance and rapid falsification in the age of big data: Why not first road test your biomarker?. OMICS A Journal of Integrative Biology, 18(11), 663-665. Final publication is Available from Mary Ann Liebert, Inc., publishers at http://dx.doi.org/10.1089/omi.2014.0132

Abstract

No abstract available.

DOI

10.1089/omi.2014.0132

Access Rights

subscription content

Link to Full Text

Share

 
COinS
 

Link to publisher version (DOI)

10.1089/omi.2014.0132